GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
74.38
-0.48 (-0.64%)
At close: Jun 27, 2025, 4:00 PM
74.12
-0.26 (-0.35%)
After-hours: Jun 27, 2025, 4:46 PM EDT
GEHC Revenue
GE HealthCare Technologies had revenue of $4.78B in the quarter ending March 31, 2025, with 2.73% growth. This brings the company's revenue in the last twelve months to $19.80B, up 1.56% year-over-year. In the year 2024, GE HealthCare Technologies had annual revenue of $19.67B with 0.61% growth.
Revenue (ttm)
$19.80B
Revenue Growth
+1.56%
P/S Ratio
1.66
Revenue / Employee
$373,566
Employees
53,000
Market Cap
34.06B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
GEHC News
- 3 days ago - FDA Approves Expanded Indications for GE HealthCare's Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer's Patients - Business Wire
- 4 days ago - GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025 - Business Wire
- 6 days ago - GE Healthcare: Near-Term Margin Headwinds Priced In, Long-Term Growth Driven By New Products And M&As - Seeking Alpha
- 6 days ago - GE HealthCare drives innovation in theranostics with latest technological advances - Business Wire
- 8 days ago - Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine - Business Wire
- 15 days ago - GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions - Business Wire
- 23 days ago - GE HealthCare: The Demand Is Just Too Strong To Ignore - Seeking Alpha
- 25 days ago - PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer - PRNewsWire